Contrôle du rejet hyperaigu de xénogreffe par la modification génétique du donneur = Control of hyperacute xenograft rejection by genetic modifying of the donorWHITE, D. J. G; GOZZI, E; LANGFORD, G et al.Actualités néphrologiques Jean Hamburger. 1994, pp 307-316, issn 1168-1098Article

The control of hyperacute rejection by genetic engineering of the donor speciesWHITE, D. J. G; COZZI, E; LANGFORD, G et al.Eye (London. 1987). 1995, Vol 9, pp 185-189, issn 0950-222X, 2Conference Paper

Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complementWHITE, D. J. G; OGLESBY, T; LISZEWSKI, M. K et al.Transplantation proceedings. 1992, Vol 24, Num 2, pp 474-476, issn 0041-1345Conference Paper

Radioassays for quantitation of intact complement proteins C2 and B in human serumOGLESBY, T. J; UEDA, A; VOLANAKIS, J. E et al.Journal of immunological methods. 1988, Vol 110, Num 1, pp 55-62, issn 0022-1759Article

The inhibition of arachidonic acid metabolism in human platelets by RHC 80267, a diacylglycerol lipase inhibitorOGLESBY, T. D; GORMAN, R. R.Biochimica et biophysica acta. 1984, Vol 793, Num 2, pp 269-277, issn 0006-3002Article

Evidence for a C4b binding site on the C2b domain of C2OGLESBY, T. J; ACCAVITTI, M. A; VOLANAKIS, J. E et al.The Journal of immunology (1950). 1988, Vol 141, Num 3, pp 926-931, issn 0022-1767Article

Evidence for 15-HETE synthesis by human umbilical vein endothelial cellsGORMAN, R. R; OGLESBY, T. D; BUNDY, G. L et al.Circulation (New York, N.Y.). 1985, Vol 72, Num 4, pp 708-712, issn 0009-7322Article

Biosynthesis and metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid by human umbilical vein endothelial cellsHOPKINS, N. K; OGLESBY, T. D; BUNDY, G. L et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 22, pp 14048-14053, issn 0021-9258Article

Complement in human reproduction: activation and controlROONEY, I. A; OGLESBY, T. J; ATKINSON, J. P et al.Immunologic research. 1993, Vol 12, Num 3, pp 276-294, issn 0257-277XArticle

Idnetification and characterization of membrane cofactor protein of human spematozoaCERVONI, F; OGLESBY, T. J; ADAMS, E.M et al.The Journal of immunology (1950). 1992, Vol 148, Num 5, pp 1431-1437, issn 0022-1767Article

Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanismOGLESBY, T. J; ALLEN, C. J; LISZEWSKI, M. K et al.The Journal of experimental medicine. 1992, Vol 175, Num 6, pp 1547-1551, issn 0022-1007Article

Separation of self from non-self in the complement system : a role for membrane cofactor protein and decay accelerating factorATKINSON, J. P; OGLESBY, T. J; WHITE, D et al.Clinical and experimental immunology (Print). 1991, Vol 86, Num OCT, pp 27-30, issn 0009-9104, SUP1Conference Paper

Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the ratMATERA, G; COOK, J. A; HENNIGAR, R. A et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 247, Num 1, pp 363-371, issn 0022-3565Article

12S,20-dihydroxyicosatetraenoic acid: A new icosanoid synthesized by neutrophils from 12S-hydroxyicosatetraenoic acid produced by thrombin- or stimulated plateletsMARCUS, A. J; SAFIER, L. B; ULLMAN, H. L et al.Proceedings of the National Academy of Sciences of the United States of America. Biological sciences. 1984, Vol 81, Num 3, pp 903-907, issn 0273-1134Article

Substituted isocoumarins as inhibitors of complement serine proteasesKAM, C.-M; OGLESBY, T. J; PANGBURN, M. K et al.The Journal of immunology (1950). 1992, Vol 149, Num 1, pp 163-168, issn 0022-1767Article

Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoaCERVONI, F; OGLESBY, T. J; FENICHEL, P et al.The Journal of immunology (1950). 1993, Vol 151, Num 2, pp 939-948, issn 0022-1767Article

Characterization of three monoclonal antibodies to membrane co-factor protein (MCP) of the complement system and quantification of MCP by radioassayCHO, S.-W; OGLESBY, T. J; HSI, B.-L et al.Clinical and experimental immunology (Print). 1991, Vol 83, Num 2, pp 257-261, issn 0009-9104, 5 p.Article

Inhibition of platelet function in thrombosisMARCUS, A. J; SAFIER, L. B; ULLMAN, H. L et al.Circulation (New York, N.Y.). 1985, Vol 72, Num 4, pp 698-701, issn 0009-7322Article

Pharmacokinetic screening of o-naphthoquinone 5-lipoxygenase inhibitorsASHOK RAKHIT; KUWAHARA, S. K; JONES, D. R et al.Pharmaceutical research. 1990, Vol 7, Num 10, pp 1071-1076, issn 0724-8741, 6 p.Article

The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46PURCELL, D. F. J; MCKENZIE, I. F. C; LUBLIN, D. M et al.Immunology (Oxford). 1990, Vol 70, Num 2, pp 155-161, issn 0019-2805Article

Stereochemistry, total synthesis, and biological activity of 14,15-dihydroxy-5,8,10,12-eicosatetraenoic acidRADMARK, O; SERHAN, C; SCAHILL, T. A et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 21, pp 13011-13016, issn 0021-9258Article

Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo modelsKU, E. C; RAYCHAUDHURI, A; GHAI, G et al.Biochimica et biophysica acta. 1988, Vol 959, Num 3, pp 332-342, issn 0006-3002Article